Abstract:Previously, we successfully developed the c(phg-isoDGRk) peptide as a novel integrin alpha(5)beta(1)-targeted SPECT imaging probe Tc-99m-HisoDGR for Glioma imaging. However, the fast clearance of Tc-99m-HisoDGR in blood reduced its tumor accumulation and retention, which would be the obstacles for further clinical application. Dimerization and albumin-binding strategies have been proven as effective approaches to improve tumor targeting capability and blood circulation time of radiotracers. In this study, the novel PEGylated dimeric isoDGR peptides (termed 3PisoDGR(2)) and its analogue with an albumin binder (termed AB-3PisoDGR(2)) were designed, and the corresponding radiotracers Tc-99m-3PisoDGR(2) and Tc-99m-AB-3PisoDGR(2) were fabricated and assessed for tumor-targeting and in vivo pharmacokinetics properties in subcutaneous and orthotopic tumor models. The dimerization of isoDGR peptide provided higher binding affinity to tumor cells and longer blood circulation time than the original monomeric isoDGR peptide, resulting in twice increased tumor uptake (Tc-99m-3PisoDGR(2) 2.51 +/- 0.17 % ID/g vs Tc-99m-PisoDGR 1.17 +/- 0.21 %ID/g, P < 0.01) at 0.5 h post-injection (p.i.) and enhanced tumor to nontargeting tissue ratios (T/NT) in most normal organs. The blocking study indicated that the tumor uptake was receptor-mediated specifically. NanoScanSPECT/CT imaging of Tc-99m-3PisoDGR(2) in glioma tumor-bearing model showed clear visions of tumors with low background, except high uptake in excretion system including kidneys and bladder at all detected time points (0.5, 1, and 2 h p.i.). The orthotopic glioma tumor could also be clearly visualized by nanoScanSPECT/CT imaging with Tc-99m-3PisoDGR(2). The addition of albumin-binding entity further prolonged blood circulation time and reached higher tumor uptake for Tc-99m-AB-3PisoDGR(2). However, since Tc-99m-AB-3PisoDGR(2) is less capable of passing BBB than Tc-99m-3PisoDGR(2), Tc-99m-3PisoDGR(2) is preferable for the in situ glioma imaging. In conclusion, Tc-99m-3PisoDGR(2) represents an improved molecular probe for integrin alpha(5)beta(1)-targeted tumor imaging, showing more potential for further clinical application.

Synthesis and Biodistribution of A New 99Mtc-Oxo Complex with Deoxyglucose Dithiocarbamate for Tumor Imaging

Preparation and biodistribution of a (99m)Tc tricarbonyl complex with deoxyglucose dithiocarbamate as a tumor imaging agent for SPECT.

99Tcmn-Dgdtc,a New Glucose Metabolic Agent,the Pharmacokinetics and Imaging Results

Synthesis and Biodistribution of Novel 99mtcn Complexes of Glucose Dithiocarbamate As Potential Probes for Tumor Imaging

Radio-Labeling and Micro-Pet Study of Cu-64 Labeled D-Glucose for Tumor Imaging

A pre-targeting strategy for imaging glucose metabolism using technetium-99m labelled dibenzocyclooctyne derivative.

Synthesis And Biodistribution Of Novel Tc-99m Labeled 4-Nitroimidazole Dithiocarbamate Complexes As Potential Agents To Target Tumor Hypoxia

Kit formulation for preparation and biological evaluation of a novel 99m Tc-oxo complex with metronidazole xanthate for imaging tumor hypoxia

Synthesis and Evaluation of (68)Ga-Labeled DOTA-2-deoxy-D-glucosamine As a Potential Radiotracer in Μpet Imaging.

Tumor Locating Property of ~(99)Tc~m-Mavgg-glucose

99m Tc-labeled colchicine for tumor imaging using DTPA as bifunctional chelating agent

(99M)tc-Labeled Dimeric Octreotide Peptide: a Radiotracer with High Tumor Uptake for Single-Photon Emission Computed Tomography Imaging of Somatostatin Receptor Subtype 2-Positive Tumors.

Synthesis and evaluation of 111 In-labeled d -glucose as a potential SPECT imaging agent

Biodistribution and Pharmacokinetics of 99tcm Labeled Carbohydrated Peptides in Mice Bearing Tumors

The preparation and biological evaluation of 99mTc-MAG3-glucose

Improved in vivo Targeting Capability and Pharmacokinetics of 99mTc-labeled isoDGR by Dimerization and Albumin-Binding for Glioma imaging.

Novel 99mTc-Labeled Mannose Derivative as a Highly Promising Single Photon Emission Computed Tomography Probe for Tumor Imaging

99m TcO(MAG 2 -3G 3 -dimer): a new integrin α v β 3 -targeted SPECT radiotracer with high tumor uptake and favorable pharmacokinetics

Gd(3+)-DTPA-DG: novel nanosized dual anticancer and molecular imaging agent

A thiourea‐bridged 99mTc(CO)3‐dipicolylamine‐2‐nitroimidazole complex for targeting tumor hypoxia: Utilizing metabolizable thiourea‐bridge to improve pharmacokinetics

<sup>99m</sup>Tc-Labeled Cyclic RGDfK Dimer: Initial Evaluation for SPECT Imaging of Glioma Integrin α<sub>v</sub>β<sub>3</sub>Expression